Safety monitoring of bivalent mRNA COVID-19 vaccine among pregnant persons in the vaccine adverse event reporting System - United States, September 1, 2022 - March 31, 2023

CONCLUSIONS: Based on this review of reports to VAERS, the safety profile of bivalent mRNA COVID-19 vaccination in pregnant persons was comparable to that observed for monovalent mRNA COVID-19 booster vaccination (3rd and 4th dose) in pregnant persons.PMID:38462432 | DOI:10.1016/j.vaccine.2024.02.084

Source: Vaccine - March 10, 2024 Category: Allergy & Immunology Authors: Pedro L Moro Grace Carlock Nimita Fifadara Tei Habenicht Bicheng Zhang Penelope Strid Paige Marquez Source Type: research